Atlas Trials

Clinical Pharmacology Study to Evaluate the Total Systemic Exposure and Lung Bioavailability of CHF 5993 pMDI Combination in Healthy Volunteers

Clinical trial NCT02359292 · COMPLETED

Trial details

NCT number
NCT02359292
Sponsor
Chiesi Farmaceutici S.p.A.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Asthma
Start date
2015-02-01
Primary completion
2015-04-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.